We have shown previously that changes in LiaFSR, a three-component regulatory system 28 predicted to orchestrate the cell membrane stress response, are important mediators of 29 daptomycin (DAP) resistance in enterococci. Indeed, deletion of the gene encoding the 30 response regulator LiaR in a clinical strain of E. faecalis, reversed DAP resistance and 31 produced a strain hypersusceptible to antimicrobial peptides. Since LiaFSR is conserved in E. 
INTRODUCTION 52
E. faecium have become one of the most recalcitrant nosocomial pathogens due to the 53 emergence of strains that exhibit multidrug resistance. Vancomycin resistance is now almost 54 universal in E. faecium isolates recovered from US hospitals and the Centers for Disease 55
Control and Prevention has deemed this pathogen a serious public health threat (1). This 56 difficult situation has also been recognized by the Infectious Diseases Society of America by the 57 inclusion of E. faecium as one of the "No-ESKAPE" pathogens (E. faecium, Staphylococcus 58 aureus, Klebsiella pneumoniae, Acinetobacter baumanii and Enterobacter spp.) (2) against 59 which new therapies are urgently needed. Interestingly, the rise of E. faecium as an important 60 nosocomial pathogen has been associated with the dissemination of a hospital-associated (HA) 61 genetic lineage, which differs from community-associated subpopulations (3, 4). antibiotic with bactericidal activity against E. faecium, has emerged as a key front-line option for 68 the treatment of severe VRE infections. However, the main challenge when DAP is used against 69 VRE is the development of resistance during the course of treatment, which has been reported 70 extensively (6-8). Using genomic and biochemical analyses of DAP-resistant (DAP-R) strains of 71 E. faecalis and E. faecium, we have provided robust evidence that development of DAP 72 resistance mainly results from mutations in two major groups of genes encoding i) proteins 73 involved in the regulation of cell envelope homeostasis, and ii) enzymes responsible for cell 74 membrane (CM) phospholipid metabolism (9-13). Among the first group of gene products, the 75 most studied is the LiaFSR system, a three-component regulatory system present in all Gram-76 positive organisms of clinical importance that is predicted to orchestrate the cell envelope stress 77 7 delivered into fusidic acid resistant-derivatives of the target E. faecium strains by conjugation. 156
First recombination integrants were selected on gentamicin (125 μg/mL) and fusidic acid (25 157 μg/mL) and subsequently plated in medium containing p-chlorophenylalanine (9, 20, 24). 158
Colonies obtained from the counterselection medium were tested by replica plating in the 159 presence of different DAP concentrations. Clones that were susceptible (or resistant in case of 160 complementation) to DAP were further purified and the deletions (or complementations) were 161 confirmed by PCR and sequencing. All candidate colonies were subjected to pulsed field gel 162 electrophoresis (PFGE) to confirm their genetic relationship with parental strains. Growth curves 163 of mutants and parentals (fusidic acid-resistant derivatives) were performed to determine if the 164 deletion altered the growth kinetics of the mutants. The mutagenesis strategy deleted 633 165 nucleotides of liaR in R446F and HOU515F and 615 nucleotides in R497F and HOU503F. 166 167 Susceptibility testing. We determined MICs of DAP, telavancin, β-lactams (ampicillin, 168 cephalotin, ceftaroline), tetracyclines (doxycycline, minocycline, tetracycline, tigecycline), 169 fosfomycin and colistin of wild-type, mutant derivatives and complemented strains by Etest 170 (bioMérieux, Marcy l'Etoile, France) on Mueller-Hinton agar following instructions from the 171 manufacturer and incubated for 24 hours. The MICs for each strain were determined in triplicate 172 with readings performed by 2 independent observers and the results were interpreted using 173 breakpoints issued by the Clinical and Laboratory Standards Institute (CLSI) (25). 174 175 Time-kill assays. Time-kill assays were performed with an initial bacterial inoculum of 10 7 176 CFU/mL in Mueller-Hinton broth (MHB) supplemented with calcium (50 mg/L). We selected 177 concentrations of DAP that were similar to those predicted to be the free peak serum DAP 178 concentrations when the antibiotic is given in humans at doses of 4 and 12 mg/kg (4 and, 13 179 μg/mL, respectively). Bacteria were enumerated at 0, 6 and 24 hours. Antibiotic carryover was 180 controlled by centrifugation to discard the supernatant and the pelleted bacteria were 181 8 suspended in 0.9% saline solution before plating (11, 26, 27) . DAP bactericidal activity was 182 defined as a reduction of 3 log 10 in CFU/mL at 24 h in comparison to the initial inoculum. The 183 limit of detection, assuming maximum plating efficiency, was 200 CFU/mL. 184
185
Binding of bodipy-daptomycin (BDP-DAP). In order to evaluate the interactions of DAP with 186 the bacterial CM, we used BDP-DAP, a fluorescent derivative of DAP, as previously described 187 (12). The assays were performed in all "wild-type" E. faecium isolates (fusidic acid-resistant 188 derivatives, Table 1 (Table 1) , including an S333L substitution in the histidine kinase YycG, a 240 member of the essential YycFG two-component regulatory system that has been implicated in 241 DAP-resistance in staphylococci (31) . Of note, R446 lacks changes in LiaFSR. We used these 242 two distinct DAP-R strains with completely different genetic backgrounds and targeted liaR 243 under the hypothesis that LiaR plays a pivotal role in CM homeostasis and DAP-resistance in all 244 E. faecium isolates, regardless of the genetic pathway leading to DAP-R/tolerance. We were 245 able to obtain non-polar deletions of both strains and complemented R497F∆liaR with the native 246 gene (which encodes a predicted LiaR protein harboring a W73C substitution). No differences 247 in growth kinetics of wild-type vs the liaR-deletion derivatives were seen in the absence of DAP 248 (Fig. S1 ). As shown in Table 1 , deletion of liaR markedly reduced the DAP MIC from 24 μg/mL 249 to 0.094 μg/mL and from 16 μg/mL to 0.25 μg/mL in R497F∆liaR and R446F∆liaR, respectively. 250
Of note, the observed DAP MICs are much lower than any DAP MIC reported for clinical strains 251 of E. faecium in our examination of the available comprehensive multinational surveillances (32, 252 33), suggesting that the deletion not only reverses DAP resistance but also generates 253 hypersusceptibility to the antibiotic. Our results support our main hypothesis that LiaR is crucial 254 for DAP-resistance and CM homeostasis in enterococci independent of the strain background or 255 the presence of substitutions in the LiaFSR system. 256
257
Deletion of liaR causes hypersusceptibility to DAP in DAP-S E. faecium. We had shown 258
previously that E. faecalis and E. faecium with DAP MICs close to the current CLSI breakpoint 259 (4 μg/mL) and, reported as DAP-S, harbor mutations in genes associated with DAP resistance 260 (10, 11). Moreover, we have shown that these changes lead to tolerance, as assessed by time-261 kill curves. Therefore, we chose two such strains (HOU503 and HOU515) with different genetic 262 backgrounds for further analysis. E. faecium HOU503 (21) has a DAP MIC of 3 μg/mL and only 263 harbors the T120A and W73C substitutions in LiaS and LiaR but no other substitution previously 264 associated with DAP resistance (Table 1 ). Strain HOU515 also exhibits an MIC of 3 μg/mL and 265 harbors a A414T substitution in the predicted YycG without changes in LiaFSR. Similar to the 266 DAP-R strains, deletion of liaR markedly decreased the MIC of DAP from 3 μg/mL to 0.064 and 267 0.047 μg/mL in HOU503F and HOU515F, respectively. Complementation (placing the gene in 268 its native chromosomal location) of liaR in HOU503FΔliaR restored the DAP MIC to "wild-type" 269 levels (3 μg/mL). Thus, our results confirm that LiaR is likely to play a role in CM homeostasis in 270
The liaR deletions are specific for DAP but no other antibiotics. In order to determine if the 273 liaR deletion effect was specific to DAP, we assessed susceptibility of the strains to other 274 antibiotics. We evaluated the MICs to several groups of antimicrobials including cell-wall acting 275 antibiotics (β-lactams, fosfomycin), lipoglycopeptides (telavancin) and protein synthesis 276 inhibitors (tetracycline class of drugs). Table S2 shows the results of the MICs. We did not 277 observe any changes in the MICs of the tested antibiotics upon deletion of liaR in the majority of 278 the strains, suggesting that the deletion was specific for DAP. However, a notable exception 279 was the liaR-deletion derivative of R446F (representative of the YycFG pathway), which 280 exhibited a 21 fold decrease in the MICs of fosfomycin (6 µg/ml) compared to the wild type 281 R446F (128 µg/ml). The fosfomycin change was associated with a decrease of 16 fold in the 282 ampicillin MIC (Table S2) . DAP to study the interactions of the antibiotic to the cell membrane of representative strains of 300 E. faecium, we previously demonstrated that antibiotic repulsion is the prominent mechanism of 301 resistance in DAP-R E. faecium, R497 and R446 (21). In contrast, the patterns of BDP-DAP 302 binding to DAP-tolerant strains, HOU503 and HOU515, were similar to a DAP-S control (E. 303 faecium DO/TX16) at low concentrations and only HOU515 displayed significantly lower BDP-304 DAP binding at high concentrations (64 µg/mL) (21). To determine whether deletion of liaR also 305 affected antibiotic interactions with the CM, we also used BDP-DAP to evaluate binding of DAP 306 to E. faecium strains and liaR-deletion mutant derivatives (Table 1) . Fig. 2 and S2 show that 307 deletion of liaR significantly increased the binding of the antibiotic molecule to the CM in DAP-R 308
isolates (R497F and R446F with MICs 24 and 16 µg/mL, respectively), a phenomenon that was 309 most evident at high BDP-DAP concentrations (64 µg/mL). In R497F, cis-complementation with13 liaR decreased the BDP-DAP binding to levels similar to wild-type strain (Fig. 2 and Fig.S2,  311 panel a), confirming the involvement of liaR in the resistance phenotype. Interestingly, in DAP-312 tolerant strains (HOU503F and HOU515F both exhibiting DAP MIC of 3 μg/mL), we did not find 313 differences in BDP-DAP binding between wild-type and liaR deletion mutant derivatives (Fig. 2  314 and Fig.2S, panel b and d) , similar to what has been previously reported (21). These findings 315 suggest that tolerance in these strains is not mediated by repulsion of the antibiotic molecule 316 from the cell surface. 317 318 DAP resistance in E. faecium is not associated with redistribution of anionic PL 319 microdomains. We have previously used the hydrophobic fluorescent dye 10-N-nonyl-acridine 320 orange (NAO) to visualize CL-enriched microdomains in E. faecalis (12, 13). NAO was shown 321 previously to associate with CL and produces fluorescence due to the ability of CL molecules to 322 cluster in microdomains in the CM providing the opportunity for NAO to form arrays between CL 323 domains (34, 35). Recent work has demonstrated that NAO is promiscuous in its binding to 324 anionic phospholipids such as (CL) and phosphatidylglycerol in E. coli (36). In E. faecalis, we 325
showed that development of DAP resistance is associated with redistribution of these presumed 326 CL microdomains which move away from the division septum to other CM areas. As we cannot 327 differentiate binding of this dye to specific PL species, we postulated that fluorescence seen in 328 this experiment represent interaction of NAO with anionic PLs. Fig. 3 shows that, as described 329 previously in E. faecalis and B. subtilis, (12, 13, 37), anionic PL microdomains concentrate at 330 the septum and polar regions in all wild-type E. faecium strains including potential future septal 331 areas. However, unlike E. faecalis (12, 13), no change in the distribution of such anionic PL 332 microdomains was observed upon deletion of liaR, independent of the MIC. Our findings 333 support the notion that high-level resistance to DAP in E. faecium is mediated by electrostatic 334 repulsion of the DAP-calcium complexes from the cell surface without apparent redistribution of 335 CM anionic phospholipid microdomains (15, 17) . 336
DISCUSSION 337
Bacteria have evolved sophisticated mechanisms to protect their CM from the attack of 338 different stressors, including antimicrobial peptides (AMP). CM integrity is of paramount 339 importance for bacterial physiological processes and, therefore, a vital structure required for cell 340 homeostasis and survival. AMPs are the most common bacterial CM-targeting molecules found 341 in nature produced by competing bacteria and host innate immune systems. DAP is a 342 lipopeptide antibiotic whose mechanism of action resembles that of AMPs including the 343 disruption of CM structure and function that eventually leads to bacterial cell death. In the 344 course of our investigations directed towards the elucidation of the molecular bases for DAP 345 resistance in enterococci (9-13, 18-22), we have found that one of the major systems involved in 346 the enterococcal CM response to DAP is the LiaFSR three-component regulatory system. 347
Indeed, we recently showed (13) that a liaR deletion generated in a DAP-R strain of E. faecalis 348 and cell division in staphylococci) (31) , also affected the susceptibility of fosfomycin and 391 ampicillin producing a 21 and 16 fold decrease in the MICs, respectively. We postulate that this 392 phenomenon might be related to the predominance of the YycFG system and peptidoglycan 393 homeostasis in DAP-R. This effect seems to be strain-dependent since we did not observe 394 susceptibility changes in other strains. The molecular basis for this effect is the subject of future 395
investigations. 396 397
Our time-kill assays suggest that the liaR deletion also restores the bactericidal activity 398 of DAP against DAP-tolerant E. faecium at concentrations likely obtained with human doses of 399 DAP 4 mg/kg, a dose that is now considered suboptimal for serious infections and emphasizing 400 the fact that hypersusceptibility to DAP is the hallmark of the liaR deletion. Interestingly, higher 401 concentrations of DAP were required to achieve bactericidal effect in derivatives of DAP-R E. 402 faecium lacking liaR (R497F∆liaR and R446F∆liaR) compared to HOU503F∆liaR and 403 HOU515F∆liaR (DAP-tolerant), albeit, still within concentrations achievable by human dosing. 404
This discrepancy in the killing activity of DAP was observed despite the fact that all liaR deletion 405 derivatives exhibited similar DAP MICs (≤ 0.25 μg/mL; Table 1 ). This observation could be 406 explained by the presence of additional mutations associated with high-level DAP-R that may 407 lead to reduced susceptibility to DAP, independent of liaFSR. For example, overexpression of 408 mutated cardiolipin synthase (Cls) has been associated with DAP-R in E. faecalis (38). Both 409 R497F and R446F harbor Cls substitutions and it is plausible that changes in expression of 410 mutated Cls could potentially reduce the activity of DAP even in the absence of LiaR, although 411 such strategy does not appear to be as successful as when LiaR is present. An alternative 412 explanation is that unidentified LiaR-independent pathways to DAP resistance may be present. 413
Finally, our BDP-DAP experiments suggest that the mechanism of high-level DAP 414 resistance in E. faecium is likely to be more similar to that described in S. aureus than in E. 415 faecalis. Indeed, unlike E. faecalis (where we have previously provided evidence that diversion 416 of DAP from the septum is the predominant strategy to prevent the killing by the antibiotic), our 417 present results suggest that electrostatic repulsion is more likely to play a prominent role in DAP 418 resistance in E. faecium. Moreover, our NAO experiments also suggest that DAP-R in E. 419 faecium is not associated with redistribution of anionic PL microdomains in the CM supporting 420 even further the "repulsion" hypothesis. 
